Tolomelli, Giulia; Mancuso, Katia; Tacchetti, Paola; Patriarca, Francesca; Galli, Monica; Pantani, Lucia; Zannetti, Beatrice; Motta, Maria Rosa; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Giudice, Valeria; Olmo, Andrea; Arpinati, Mario; Chirumbolo, Gabriella; Fanin, Renato; Lewis, Russell E; Paris, Laura; Bonifazi, Francesca; Cavo, Michele; Curti, Antonio; Lemoli, Roberto M, The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma, «BONE MARROW TRANSPLANTATION», 2020, 55, pp. 946 - 954 [Scientific article]
Tolomelli G.; Mancuso K.; Tacchetti P.; Patriarca F.; Galli M.; Pantani L.; Zannetti B.; Motta M.R.; Rizzi S.; Dan E.; Sinigaglia B.; Giudice V.; Olmo A.; Arpinati M.; Chirumbolo G.; Fanin R.; Lewis R.E.; Paris L.; Bonifazi F.; Cavo M.; Curti A.; Lemoli R.M., The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma, «BONE MARROW TRANSPLANTATION», 2020, 55, pp. 946 - 954 [Scientific article]
Kumar S.K.; Harrison S.J.; Cavo M.; de la Rubia J.; Popat R.; Gasparetto C.; Hungria V.; Salwender H.; Suzuki K.; Kim I.; Punnoose E.A.; Hong W.-J.; Freise K.J.; Yang X.; Sood A.; Jalaluddin M.; Ross J.A.; Ward J.E.; Maciag P.C.; Moreau P., Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial, «THE LANCET ONCOLOGY», 2020, 21, pp. 1630 - 1642 [Scientific article]
Di Bacco A.; Bahlis N.J.; Munshi N.C.; Avet-Loiseau H.; Masszi T.; Viterbo L.; Pour L.; Ganly P.; Cavo M.; Langer C.; Kumar S.K.; Rajkumar S.V.; Keats J.J.; Berg D.; Lin J.; Li B.; Badola S.; Shen L.; Zhang J.; Esseltine D.-L.; Luptakova K.; van de Velde H.; Richardson P.G.; Moreau P., c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2020, 105, pp. 35 - 46 [Scientific article]Open Access
Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies, «HEMATOLOGICAL ONCOLOGY», 2019, 37, pp. 202 - 204 [Scientific article]
Simonetti, Giorgia*; Padella, Antonella; do Valle, Italo Farìa; Fontana, Maria Chiara; Fonzi, Eugenio; Bruno, Samantha; Baldazzi, Carmen; Guadagnuolo, Viviana; Manfrini, Marco; Ferrari, Anna; Paolini, Stefania; Papayannidis, Cristina; Marconi, Giovanni; Franchini, Eugenia; Zuffa, Elisa; Laginestra, Maria Antonella; Zanotti, Federica; Astolfi, Annalisa; Iacobucci, Ilaria; Bernardi, Simona; Sazzini, Marco; Ficarra, Elisa; Hernandez, Jesus Maria; Vandenberghe, Peter; Cools, Jan; Bullinger, Lars; Ottaviani, Emanuela; Testoni, Nicoletta; Cavo, Michele; Haferlach, Torsten; Castellani, Gastone; Remondini, Daniel; Martinelli, Giovanni, Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery, «CANCER», 2019, 125, pp. 712 - 725 [Scientific article]Open Access
Broccoli, Alessandro; Bertuzzi, Clara; Fiorentino, Michelangelo; Morigi, Alice; Stefoni, Vittorio; Agostinelli, Claudio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia, «ONCOTARGETS AND THERAPY», 2019, 12, Article number: 12 , pp. 4807 - 4812 [Scientific article]Open Access
Ocadlikova, Darina; Lecciso, Mariangela; Isidori, Alessandro; Loscocco, Federica; Visani, Giuseppe; Amadori, Sergio; Cavo, Michele; Curti, Antonio, Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia, «FRONTIERS IN ONCOLOGY», 2019, 9, pp. 1004 - 1004 [Scientific article]Open Access
Barone M.; Ricci F.; Sollazzo D.; Ottaviani E.; Romano M.; Auteri G.; Bartoletti D.; Reggiani M.L.B.; Vianelli N.; Tazzari P.L.; Cavo M.; Forte D.; Palandri F.; Catani L., Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis, «BRITISH JOURNAL OF HAEMATOLOGY», 2019, 185, pp. 987 - 991 [Scientific article]
Stanzani, Marta; Vianelli, Nicola; Cavo, Michele; Kontoyiannis, Dimitrios P.; Lewis, Russell E.*, Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies, «JOURNAL OF INFECTION», 2019, 78, pp. 484 - 490 [Scientific article]
Breccia, Massimo; Luciano, Luigiana; Pugliese, Novella; Rossi, Elena; Tiribelli, Mario; Scalzulli, Emilia; Bonifacio, Massimiliano; Martino, Bruno; Latagliata, Roberto; Benevolo, Giulia; Caocci, Giovanni; Binotto, Gianni; Martinelli, Vincenzo; Cavo, Michele; Pane, Fabrizio; De Stefano, Valerio; Foà, Robin; Palandri, Francesca, Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis, «ANNALS OF HEMATOLOGY», 2019, 98, pp. 1933 - 1936 [Scientific article]
Raab, Marc S; Fink, Leah; Schoen, Paul; Gonzalez-McQuire, Sebastian; Flinois, Alain; Cavo, Michele; Mateos, Maria-Victoria; Yong, Kwee, Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016, «BRITISH JOURNAL OF HAEMATOLOGY», 2019, 185, pp. 981 - 984 [Scientific article]
Offidani, M; Boccadoro, M; Di Raimondo, F; Petrucci, M T; Tosi, P; Cavo, M, Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma, «CURRENT HEMATOLOGIC MALIGNANCY REPORTS», 2019, 14, pp. 187 - 196 [Scientific article]
Cavo, Michele, Facing lenalidomide-refractory myeloma, «BLOOD», 2019, 134, pp. 99 - 101 [Scientific article]
Cavo M.; Tacchetti P.; Zamagni E., Front-line treatment of multiple myeloma, «HEMASPHERE», 2019, 3, pp. 127 - 130 [Scientific article]
